FDA investigates secondary malignancy risk with CAR T-cell therapy
The TGA is closely watching an overseas investigation of chimeric antigen receptor T-cell therapies after reports of secondary malignancies in treated patients. Last month, the…
Specialist Updates
In-depth coverage of specialist medicine
Lower recurrence rate with endoscopic submucosal dissection of large colonic lesions
For patients with large benign colonic lesions, endoscopic submucosal dissection is associated with reduced recurrence at six months compared with endoscopic mucosal resection, according to…
Isthmocele, not prior C-section, lowers IVF success rate: study
Isthmocele formation after a previous caesarean section — rather than the C-section itself — lowers the odds of a live birth in women undergoing IVF,…
Reproductive lifespan tied to post-menopausal handgrip strength
For postmenopausal women, a longer reproductive period is associated with a reduced risk for low handgrip strength, according to a study in Menopause. Dr Sae…
Colon cancer resection type ‘most important predictor’ of anastomotic leak
Total colectomy is the most significant risk factor for anastomotic leak following colon cancer resections, putting patients at four times higher risk of the catastrophic…
Delayed cord clamping ‘best treatment’ for cutting preterm infant mortality
Preterm infants are 32% less likely to die with delayed versus immediate umbilical cord clamping, according to Australian researchers who say their findings will inform…
Osimertinib-chemo combo boosts progression-free survival in EGFR-mutated lung cancer: study
Adding chemotherapy to oral osimertinib in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer prolongs progression-free survival by up to nine months,…
Offer salpingo-oophorectomy with C-section in BRCA mutation carriers: gynaecologists
Prophylactic bilateral salpingo-oophorectomy should be offered at time of obstetric-indicated caesarean delivery in women with the BRCA1 or BRCA2 pathogenic variants, say UK gynaecologists. In…
Add-on biologic a boon for kids with moderate to severe asthma: study
Fortnightly dupilumab with standard therapy leads to rapid and sustained improvements in asthma control for 6-11 year-olds with moderate to severe type 2 asthma, research…
COSA’s 50th ASM: Dr Belinda Yeo talks metastatic breast cancer, fertility and AI in oncology
On Wednesday, hundreds of Australian and overseas doctors will attend the opening of the Clinical Oncology Society of Australia’s 50th Annual Scientific Meeting in Melbourne.…
